Abstract:Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from problems of resistance and side-effects. Photoactivatable Pt-IV prodrugs offer the potential of targeted drug release and new mechanisms of action. We report the synthesis, X-ray crystallographic and spectroscopic properties of photoactivatable diazido complexes trans,trans,trans-[Pt(N-3)(2)(OH)(2)(MA)(Py)] (1; MA=methylamine, Py=pyridine) and trans,trans,trans-[Pt(N-3)(2)(OH)(2)(MA)(Tz)] (2; Tz=thiazole), and interpret their photophysical properties by TD-DFT modelling. The orientation of the azido groups is highly dependent on Hbonding and crystal packing, as shown by polymorphs 1p and 1q. Complexes 1 and 2 are stable in the dark towards hydrolysis and glutathione reduction, but undergo rapid photoreduction with UVA or blue light with minimal amine photodissociation. They are over an order of magnitude more potent towards HaCaT keratinocytes, A2780 ovarian, and OE19 oesophageal carcinoma cells than cisplatin and show particular potency towards cisplatin-resistant human ovarian cancer cells (A2780cis). Analysis of binding to calf-thymus (CT), plasmids, oligonucleotide DNA and individual nucleotides reveals that photoactivated 1 and 2 form both mono- and bifunctional DNA lesions, with preference for G and C, similar to transplatin, but with significantly larger unwinding angles and a higher percentage of interstrand cross-links, with evidence for DNA strand cross-linking further supported by a comet assay. DNA lesions of 1 and 2 on a 50bp duplex were not recognised by HMGB1 protein, in contrast to cisplatin-type lesions. The photo-induced platination reactions of DNA by 1 and 2 show similarities with the products of the dark reactions of the Pt-II compounds trans-[PtCl2(MA)(Py)] (5) and trans-[PtCl2(MA)(Tz)] (6). Following photoactivation, complex 2 reacted most rapidly with CT DNA, followed by 1, whereas the dark reactions of 5 and 6 with DNA were comparatively slow. Complexes 1 and 2 can therefore give rapid potent photocytotoxicity and novel DNA lesions in cancer cells, with no activity in the absence of irradiation.

Monofunctional Platinum Complexes Containing a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore: Distribution in Tumour Cells.

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

A novel benzothiazole-based mononuclear platinum(II) complex displaying potent antiproliferative activity in HepG-2 cells via mitochondrial-mediated apoptosis

Study on the Cytotoxic Activity of Platinum(ii) Complexes of (1 R ,2 R )- N 1 -Cyclopentyl-1,2-cyclohexanediamine with Substituted Malonate Derivatives

Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.

Metal complexes as photochemical nitric oxide precursors : Potential applications in the treatment of tumors

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands

Platinum(Ii) Complexes with N-Monoalkyl 1R,2r-Diaminocyclohexane Derivatives As Carrier Ligands and 3-Hydroxycyclobutane-1,1-dicarboxylate As A Leaving Group: Potent Cytotoxicity and Dna Binding Ability

Synthesis, Cytotoxicity, Induction of Apoptosis, and Interaction with DNA of Dinuclear Platinum(II) Complexes

Imaging of the nuclei of living tumor cells by novel ruthenium(II) complexes coordinated with 6-chloro-5-hydroxylpyrido[3,2-a]phenazine

Antitumor Active Monofunctional Platinum(ii) Complexes: Synthesis, Structural Characterization and Reactivity Towards Biomolecules

Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.

Binuclear Monofunctional Platinum(ii) Complexes Formed by Hexaazamacrocyclic Bisdien Ligands: Crystal Structure, DNA Binding and Cytotoxicity Studies

Synthesis and Biological Evaluation of Mixed Ammine/amine Platinum(ii) Complexes with Dicarboxylate Containing Organic Nitrate As Ligand

Design, Synthesis, and Biological Features of Platinum(Ii) Complexes with Rigid Steric Hindrance

Two novel SNS-donor palladium(II) complexes of benzoxazole and benzothiazole derivatives as potential anticancer agentsPlease do not adjust margins

Luminescent Cyclometalated Platinum(Ii) Complex Forms Emissive Intercalating Adducts with Double-Stranded Dna and Rna: Differential Emissions and Anticancer Activities

Synthesis, Cytotoxicity, and Apoptosis Induction Study of Antitumor Dinuclear Platinum(ii) Complexes.

Antitumor Platinum(ii) Complexes of N-cyclobutyl-1R,2R-diaminocyclohexane with Dicarboxylates As Leaving Groups

Pincer-Type Platinum(II) Complexes Containing N-Heterocyclic Carbene (NHC) Ligand: Structures, Photophysical and Anion-Binding Properties, and Anticancer Activities.

Nucleus-Localized Platinum(Ii)-Triphenylamine Complexes As Potent Photodynamic Anticancer Agents